Target intelligence / Profile preview

Long intergenic non-protein coding RNA 114 (LINC00114)

Target
LINC00114
Molecular classification
Long non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 114 (LINC00114) is a long non-coding RNA molecule expressed in both the cytoplasm and nucleus. Highly upregulated in colorectal cancer, it acts as an oncogenic factor by suppressing the tumor suppressor miRNA miR-133b, predominantly via recruitment of the methyltransferase EZH2 and DNMT1, which leads to methylation-induced silencing of miR-133b's promoter. This, in turn, derepresses NUP214, a protein promoting cancer cell proliferation. Experimental knockdown of LINC00114 inhibits colorectal cancer cell growth in vitro and in vivo, suggesting that LINC00114 is both a mechanistic driver of cancer progression and a promising diagnostic and therapeutic target in oncology.

Other names
LINC00114C21orf24NCRNA00114Chromosome 21 open reading frame 24
02

Mechanism of action

Drugs such as RG108 act by inhibiting DNA methyltransferase, which can counteract the LINC00114-driven epigenetic silencing of miR-133b promoter, restoring tumor suppressor miRNA activity

03

Biological functions

Regulation of DNA methylationModulation of miRNA (miR-133b) levels via sponging and epigenetic mechanismsCell cycle progression control (G1/S phase checkpoint)Promotion of cancer cell proliferation
04

Disease associations

Cancer (specifically colorectal cancer)
05

Safety considerations

Experimental, no established clinical safety concerns specifically linked to LINC00114-targeting interventions; general concerns are related to off-target effects of epigenetic drugs (e.g., methyltransferase inhibitors)
06

Interacting drugs

RG108
07

Biomarkers

LINC00114 expression level in tissue (overexpression associated with poor prognosis in CRC)miR-133b expression levelDNA methylation status of miR-133b promoter

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 114 (LINC00114).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 114 (LINC00114).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call